Gandara DR - Search Results

1

Current status of adjuvant chemotherapy for stage IB non-small-cell lung cancer: implications for the New Intergroup Trial.

Wakelee HA, Schiller JH, Gandara DR. Wakelee HA, et al. Among authors: gandara dr. Clin Lung Cancer. 2006 Jul;8(1):18-21. doi: 10.3816/CLC.2006.n.028. Clin Lung Cancer. 2006. PMID: 16870041 Review.

2

Late consolidative radiation therapy in the treatment of limited-stage small cell lung cancer.

Carlson RW, Sikic BI, Gandara DR, Hendrickson CG, Wittlinger PS, Shields JA, Wong PP, White JE, Meakin CJ, McWhirter KM, et al. Carlson RW, et al. Among authors: gandara dr. Cancer. 1991 Sep 1;68(5):948-58. doi: 10.1002/1097-0142(19910901)68:5<948::aid-cncr2820680507>3.0.co;2-1. Cancer. 1991. PMID: 1655219 Clinical Trial.

3

High-dose cisplatin and mitomycin C in advanced non-small cell lung cancer: a phase II study of the Northern California Oncology Group.

Gandara DR, Perez EA, Wold H, Caggiano V, Malec M, Ahn DK, Meyers F, Carlson RW. Gandara DR, et al. Cancer Chemother Pharmacol. 1990;27(3):243-7. doi: 10.1007/BF00685721. Cancer Chemother Pharmacol. 1990. PMID: 2176134 Clinical Trial.

4

Etoposide/ifosfamide/cisplatin regimens in metastatic non-small cell lung cancer.

Perez EA, Gandara DR. Perez EA, et al. Among authors: gandara dr. Semin Oncol. 1994 Jun;21(3 Suppl 4):2-5. Semin Oncol. 1994. PMID: 8209273 Review.

5

Concurrent carboplatin, etoposide and thoracic radiation for poor-risk stage III non-small-cell lung carcinoma: a pilot study.

Lau DH, Ryu JK, Gandara DR, Rosenthal SA. Lau DH, et al. Among authors: gandara dr. Int J Radiat Oncol Biol Phys. 1997 Apr 1;38(1):157-61. doi: 10.1016/s0360-3016(97)00249-6. Int J Radiat Oncol Biol Phys. 1997. PMID: 9212018

6

Twice-weekly paclitaxel and radiation for stage III non-small cell lung cancer.

Lau DH, Ryu JK, Gandara DR, Morgan R, Doroshow J, Wilder R, Leigh B. Lau DH, et al. Among authors: gandara dr. Semin Oncol. 1997 Aug;24(4 Suppl 12):S12-106-S12-109. Semin Oncol. 1997. PMID: 9331132 Clinical Trial.

7

Chemoradiotherapy for poor-risk stage III non-small cell lung cancer.

Lau DH, Ryu JK, Gandara DR. Lau DH, et al. Among authors: gandara dr. Semin Oncol. 1997 Aug;24(4 Suppl 12):S12-110-S12-112. Semin Oncol. 1997. PMID: 9331133 Clinical Trial.

8

Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancer.

Lau DH, Crowley JJ, Gandara DR, Hazuka MB, Albain KS, Leigh B, Fletcher WS, Lanier KS, Keiser WL, Livingston RB. Lau DH, et al. Among authors: gandara dr. J Clin Oncol. 1998 Sep;16(9):3078-81. doi: 10.1200/JCO.1998.16.9.3078. J Clin Oncol. 1998. PMID: 9738578 Clinical Trial.

9

High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer: targeted plasma levels are achievable clinically.

Lara PN Jr, Gandara DR, Wurz GT, Lau D, Uhrich M, Turrell C, Raschko J, Edelman MJ, Synold T, Doroshow J, Muggia F, Perez EA, DeGregorio M. Lara PN Jr, et al. Among authors: gandara dr. Cancer Chemother Pharmacol. 1998;42(6):504-8. doi: 10.1007/s002800050852. Cancer Chemother Pharmacol. 1998. PMID: 9788578 Clinical Trial.

10

Gemcitabine and carboplatin in combination: an update of phase I and phase II studies in non-small cell lung cancer.

Langer CJ, Gandara DR, Calvert P, Edelman MJ, Ozols RF. Langer CJ, et al. Among authors: gandara dr. Semin Oncol. 1999 Feb;26(1 Suppl 4):12-8. Semin Oncol. 1999. PMID: 10201516 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

451 results

Search Page

Filters